{"database": "openregs", "table": "legislation", "rows": [["104-hres-527", 104, "hres", 527, "Relating to breast implants, the Food and Drug Administration, and public health.", "Health", "1996-09-19", "1996-09-25", "Referred to the Subcommittee on Health and Environment.", "House", "Rep. McIntosh, David M. [R-IN-2]", "IN", "R", "M000481", 0, "Expresses the sense of the House of Representatives that the Food and Drug Administration should:  (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases.", "2024-02-05T14:30:09Z", null]], "columns": ["bill_id", "congress", "bill_type", "bill_number", "title", "policy_area", "introduced_date", "latest_action_date", "latest_action_text", "origin_chamber", "sponsor_name", "sponsor_state", "sponsor_party", "sponsor_bioguide_id", "cosponsor_count", "summary_text", "update_date", "url"], "primary_keys": ["bill_id"], "primary_key_values": ["104-hres-527"], "units": {}, "query_ms": 25.327403098344803, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}